SLC5A2 and dementia: Xu et al. conducted a comprehensive meta-analysis of 52 trials/publications, encompassing 111376 participants, and similarly reported no significant effect of SGLT2 inhibitors on the incidence of dementia (RR: 1.29; 95% CI: 0.78-2.12) [13].